Roche announced that Lucentis ( ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema ( DME ), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness.